Showing results (761-770 of 1,877) with videos related to

Sort By:
Pageof 188
Immunotherapy|March 15, 2016
The antileukemic potential of natural killer cellsGiovanni F Torelli, Nadia Peragine, Paola Mariglia, et al.
Immunotherapy|March 15, 2016
Mesothelin as a target for chimeric antigen receptor-modified T cells as anticancer therapyMark O'Hara, Caitlin Stashwick, Andrew R Haas, et al.
Immunotherapy|March 15, 2016
Hepatitis B immunopathogenesis and immunotherapyForough Golsaz-Shirazi, Fazel Shokri
Immunotherapy|March 15, 2016
The role of PD-L1 expression as a predictive biomarker in advanced non-small-cell lung cancer: a network meta-analysisPedro N Aguiar, Ilka Lopes Santoro, Hakaru Tadokoro, et al.
Immunotherapy|September 4, 2020
Outcomes following immunotherapy re-challenge after immune-related adverse event: systematic review and meta-analysisRobin Park, Laercio Lopes, Anwaar Saeed
Immunotherapy|November 23, 2020
Rechallenge of anti-PD-1/PD-L1 antibody showed a good response to metastatic breast cancer: a case reportYoko Otani, Kiyoshi Mori, Nozomi Morikawa, et al.
Immunotherapy|November 23, 2020
Immortal time bias in the association between toxicity and response for immune checkpoint inhibitors: a meta-analysisFilippo Gustavo Dall'Olio, Alessandro Rizzo, Veronica Mollica, et al.
Immunotherapy|November 24, 2020
Front-line daratumumab-VTd versus standard-of-care in ASCT-eligible multiple myeloma: matching-adjusted indirect comparisonPhilippe Moreau, Benjamin Hebraud, Thierry Facon, et al.
Immunotherapy|September 9, 2020
COVID-19 in a patient with advanced Merkel cell carcinoma receiving immunotherapyCesar Martins da Costa, Zenaide Silva de Souza, Alessandra Corte Real Salgues, et al.
Immunotherapy|November 17, 2020
rHuPH20-facilitated subcutaneous administration of monoclonal antibodies in cancer therapyWenliang Dong, Min Chen, Jiaxue Wang, et al.
Pageof 188